Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations Meeting Abstract
| Authors: | Ho, A. L.; Chau, N.; Bauman, J.; Bible, K.; Chintakuntlawar, A.; Cabanillas, M. E.; Wong, D. J.; Garcia, I. B.; Brose, M. S.; Boni, V.; Even, C.; Razaq, M.; Mishra, V.; Bracken, K.; Wages, D.; Scholz, C.; Gualberto, A. |
| Abstract Title: | Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy287.002 |
| Language: | English |
| ACCESSION: | WOS:000459277302224 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy287.002 |
| Notes: | Meeting Abstract: 1046O -- Appears on page viii373 of the abstract book -- Source: Wos |
